A cytosolic relay of heat shock proteins HSP70-1A and HSP90β Monitors the Folding trajectory of the serotonin transporter

Journal of Biological Chemistry

Volumn 289, Issue 42, 2014, Pages 28987-29000

  El Kasaby, Ali ^a,b   Koban, Florian ^a   Sitte, Harald H ^a   Freissmuth, Michael ^a   Sucic, Sonja ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Mansoura University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; COBALT COMPOUNDS; ENERGY TRANSFER;

ATP-ASE ACTIVITY; CELL SURFACE EXPRESSION; CO-IMMUNOPRECIPITATIONS; COMPLEX FORMATIONS; ENDOPLASMIC RETICULUM; HEAT SHOCK PROTEIN; RESONANCE ENERGY TRANSFER; SEROTONIN TRANSPORTERS;

PROTEINS;

ADENOSINE TRIPHOSPHATASE; ALVESPIMYCIN; CHAPERONE; HEAT SHOCK COGNATE PROTEIN 70 HEAT SHOCK PROTEIN 90 ORGANIZING PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70 1A; HEAT SHOCK PROTEIN 90 BETA; NORIBOGAINE; SEROTONIN TRANSPORTER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70L1, HUMAN; HEAT SHOCK PROTEIN 90; HSP90AB1 PROTEIN, HUMAN; IBOGAINE; SLC6A4 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOLIC HEAT SHOCK PROTEIN RELAY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE SILENCING; HEK293 CELL LINE; HUMAN; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; WILD TYPE; ANALOGS AND DERIVATIVES; CHEMISTRY; CYTOSOL; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

ADENOSINE TRIPHOSPHATASES; CYTOSOL; ENDOPLASMIC RETICULUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; GLUTATHIONE TRANSFERASE; HEK293 CELLS; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IBOGAINE; MUTATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84908110301     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.595090     Document Type: Article

References (49)

1. Hebert, D. N., and Molinari, M. (2007) In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol. Rev. 87, 1377-1408
2. Sanders, C. R., and Myers, J. K. (2004) Disease-related misassembly of membrane proteins. Annu. Rev. Biophys. Biomol. Struct. 33, 25-51
3. Ng, D. P., Poulsen, B. E., and Deber, C. M. (2012) Membrane protein misassembly in disease. Biochim. Biophys. Acta 1818, 1115-1122
4. Chiba, P., Freissmuth, M., and Stockner, T. (2014) Defining the blanks: pharmacochaperoning of SLC6 transporters and ABC transporters. Pharmacol. Res. 83, 63-73
5. Kurian, M. A., Zhen, J., Cheng, S. Y., Li, Y., Mordekar, S. R., Jardine, P., Morgan, N. V., Meyer, E., Tee, L., Pasha, S., Wassmer, E., Heales, S. J., Gissen, P., Reith, M. E., and Maher, E. R. (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J. Clin. Investig. 119, 1595-1603
6. Kurian, M. A., Li, Y., Zhen, J., Meyer, E., Hai, N., Christen, H. J., Hoffmann, G. F., Jardine, P., von Moers, A., Mordekar, S. R., O'Callaghan, F., Wassmer, E., Wraige, E., Dietrich, C., Lewis, T., Hyland, K., Heales, S., 1658., Sanger, T., Gissen, P., Assmann, B. E., Reith, M. E., and Maher, E. R. (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 10, 54-62
7. Ng, J., Zhen, J., Meyer, E., Erreger, K., Li Y., Kakar, N., Ahmad, J., Thiele, H., Kubisch, C., Rider, N. L., Morton, D. H., Strauss, K. A., Puffenberger, E. G., D'Agnano, D., Anikster, Y., Carducci, C., Hyland, K., Rotstein, M., Leuzzi, V., Borck, G., Reith, M. E., and Kurian, M. A. (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137, 1107-1119
8. Hahn, M. K., Robertson, D., and Blakely, R. D. (2003) A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J. Neurosci. 23, 4470-4478
9. Rees, M. I., Harvey, K., Pearce, B. R., Chung, S. K., Duguid, I. C., Thomas, P., Beatty, S., Graham, G. E., Armstrong, L., Shiang, R., Abbott, K. J., Zuberi, S. M., Stephenson, J. B., Owen, M. J., Tijssen, M. A., van den Maagdenberg, A. M., Smart, T. G., Supplisson, S., and Harvey, R. J. (2006) Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat. Genet. 38, 801-806
10. Carta, E., Chung, S. K., James, V. M., Robinson, A., Gill, J. L., Remy, N., Vanbellinghen, J. F., Drew, C. J., Cagdas, S., Cameron, D., Cowan, F. M., Del Toro, M., Graham, G. E., Manzur, A. Y., Masri, A., Rivera, S., Scalais, E., Shiang, R., Sinclair, K., Stuart, C. A., Tijssen, M. A., Wise, G., Zuberi, S. M., Harvey, K., Pearce, B. R., Topf, M., Thomas, R. H., Supplisson, S., Rees, M. I., and Harvey, R. J. (2012) Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J. Biol. Chem. 287, 28975-28985
11. Giménez, C., Pérez-Siles, G., Martínez-Villarreal, J., Arribas-González, E., Jiménez, E., Núñez, E., de Juan-Sanz, J., Fernández-Sánchez, E., García-Tardón, N., Ibáñez, I., Romanelli, V., Nevado, J., James, V. M., Topf, M., Chung, S. K., Thomas, R. H., Desviat, L. R, Aragón, C., Zafra, F., Rees, M. I., Lapunzina, P., Harvey, R. J., and López-Corcuera, B. (2012) A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2. J. Biol. Chem. 287, 28986-29002
12. Schmid, J. A., Scholze, P., Kudlacek, O., Freissmuth, M., Singer, E. A., and Sitte, H. H. (2001) Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276, 3805-3810
13. Scholze, P., Freissmuth, M., and Sitte, H. H. (2002) Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1. J. Biol. Chem. 277, 43682-43690
14. Farhan, H., Korkhov, V. M., Paulitschke, V., Dorostkar, M. M., Scholze, P., Kudlacek, O., Freissmuth, M., and Sitte, H. H. (2004) Two discontinuous segments in the carboxyl terminus are required for membrane targeting of the rat γ-aminobutyric acid transporter-1 (GAT1). J. Biol. Chem. 279, 28553-28563
15. Just, H., Sitte, H. H., Schmid, J. A., Freissmuth, M., and Kudlacek, O. (2004) Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter. J. Biol. Chem. 279, 6650-6657
16. Korkhov, V. M., Milan-Lobo, L., Zuber, B., Farhan, H., Schmid, J. A., Freissmuth, M., and Sitte, H. H. (2008) Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies. J. Mol. Biol. 378, 337-352
17. Farhan, H., Reiterer, V., Korkhov, V. M., Schmid, J. A., Freissmuth, M., and Sitte, H. H. (2007) Concentrative export from the endoplasmic reticulum of the γ-aminobutyric acid transporter 1 requires binding to SEC24D. J. Biol. Chem. 282, 7679-7689
18. Sucic, S., El-Kasaby, A., Kudlacek, O., Sarker, S., Sitte, H. H., Marin, P., and Freissmuth, M. (2011) The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. J. Biol. Chem. 286, 16482-16490
19. Sucic, S., Koban, F., El-Kasaby, A., Kudlacek, O., Stockner, T., Sitte, H. H., and Freissmuth, M. (2013) Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C. J. Biol. Chem. 288, 5330-5341
20. El-Kasaby, A., Just, H., Malle, E., Stolt-Bergner, P. C., Sitte, H. H., Freissmuth, M., and Kudlacek, O. (2010) Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter. J. Biol. Chem. 285, 39201-39210
21. Jacobs, M. T., Zhang, Y. W., Campbell, S. D., and Rudnick, G. (2007) Ibogaine, a noncompetitive inhibitor of serotonin transport, acts by stabilizing the cytoplasm-facing state of the transporter. J. Biol. Chem. 282, 29441-29447
22. Bulling, S., Schicker, K., Zhang, Y. W., Steinkellner, T., Stockner, T., Gruber, C. W., Boehm, S., Freissmuth, M., Rudnick, G., Sitte, H. H., and Sandtner, W. (2012) The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters. J. Biol. Chem. 287, 18524-18534
23. Larsen, M. B., Fjorback, A. W., and Wiborg, O. (2006) The C-terminus is critical for the functional expression of the human serotonin transporter. Biochemistry 45, 1331-1337
24. Sucic, S., Dallinger, S., Zdrazil, B., Weissensteiner, R., Jørgensen, T. N., Holy, M., Kudlacek, O., Seidel, S., Cha, J. H., Gether, U., Newman, A. H., Ecker, G. F., Freissmuth, M., and Sitte, H. H. (2010) The amino terminus of monoamine transporters is a lever required for the action of amphetamines. J. Biol. Chem. 285, 10924-10938
25. Feige, J. N., Sage, D., Wahli, W., Desvergne, B., and Gelman, L. (2005) PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc. Res. Tech. 68, 51-58
26. Zhu, X., Zhao, X., Burkholder, W. F., Gragerov, A., Ogata, C. M., Gottesman, M. E., and Hendrickson, W. A. (1996) Structural analysis of substrate binding by the molecular chaperone DnaK. Science 272, 1606-1614
27. Van Durme, J., Maurer-Stroh, S., Gallardo, R., Wilkinson, H., Rousseau, F., and Schymkowitz, J. (2009) Accurate prediction of DnaK-peptide binding via homology modelling and experimental data. PLoS Comput. Biol. 5, e1000475
28. Karzai, A. W., and McMacken, R. (1996) A bipartite signaling mechanism involved in DnaJ-mediated activation of the Escherichia coli DnaK protein. J. Biol. Chem. 271, 11236-11246
29. Laufen, T., Mayer, M. P., Beisel, C., Klostermeier, D., Mogk, A., Reinstein, J., and Bukau, B. (1999) Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc. Natl. Acad. Sci. U.S.A. 96, 5452-5457
30. Hartl, F. U., Bracher, A., and Hayer-Hartl, M. (2011) Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332
31. Schlecht, R., Scholz, S. R., Dahmen, H., Wegener, A., Sirrenberg, C., Musil, D., Bomke, J., Eggenweiler, H. M., Mayer, M. P., and Bukau, B. (2013) Functional analysis of Hsp70 inhibitors. PLoS One 8, e78443
32. Leu, J. I., Pimkina, J., Frank, A., Murphy, M. E., and George, D. L. (2009) A small molecule inhibitor of inducible heat shock protein 70. Mol. Cell 36, 15-27
33. Onuoha, S. C., Mukund, S. R., Coulstock, E. T., Sengerovà, B., Shaw, J., McLaughlin, S. H., and Jackson, S. E. (2007) Mechanistic studies on Hsp90 inhibition by ansamycin derivatives. J. Mol. Biol. 372, 287-297
34. Hohenegger, M., Mitterauer, T., Voss, T., Nanoff, C., and Freissmuth, M. (1996) Thiophosphorylation of the G protein β-subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to Gα-subunits. Mol. Pharmacol. 49, 73-80
35. Zhong, H., Sánchez, C., and Caron, M. G. (2012) Consideration of allosterism and interacting proteins in the physiological functions of the serotonin transporter. Biochem. Pharmacol. 83, 435-442
36. Seimandi, M., Seyer, P., Park, C. S., Vandermoere, F., Chanrion, B., Bockaert, J., Mansuy, I. M., and Marin, P. (2013) Calcineurin interacts with the serotonin transporter C-terminus to modulate its plasma membrane expression and serotonin uptake. J. Neurosci. 33, 16189-16199
37. Chanrion, B., Mannoury la Cour, C., Bertaso, F., Lerner-Natoli, M., Freissmuth, M., Millan, M. J., Bockaert, J., and Marin, P. (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc. Natl. Acad. Sci. U.S.A. 104, 8119-8124
38. Keuerleber, S., Gsandtner, I., and Freissmuth, M. (2011) From cradle to twilight: the carboxyl terminus directs the fate of the A2A-adenosine receptor. Biochim. Biophys. Acta 1808, 1350-1357
39. Coppinger, J. A., Hutt, D. M., Razvi, A., Koulov, A. V., Pankow, S., Yates, J. R., 3rd, and Balch, W. E. (2012) A chaperone trap contributes to the onset of cystic fibrosis. PLoS One 7, e37682
40. Chanoux, R. A., and Rubenstein, R. C. (2012) Molecular chaperones as targets to circumvent the CFTR defect in cystic fibrosis. Front. Pharmacol. 3, 137
41. Donnelly, B. F., Needham, P. G., Snyder, A. C., Roy, A., Khadem, S., Brodsky, J. L., and Subramanya, A. R. (2013) Hsp70 and Hsp90 multichaperone complexes sequentially regulate thiazide-sensitive cotransporter endoplasmic reticulum-associated degradation and biogenesis. J. Biol. Chem. 288, 13124-13135
42. Lee, K., Hong, T. J., and Hahn, J. S. (2012) Roles of 17-AAG-induced molecular chaperones and Rma1 E3 ubiquitin ligase in folding and degradation of Pendrin. FEBS Lett. 586, 2535-2541
43. Bergmayr, C., Thurner, P., Keuerleber, S., Kudlacek, O., Nanoff, C., Freissmuth, M., and Gruber, C. W. (2013) Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor. J. Biol. Chem. 288, 28831-28844
44. Rahbek-Clemmensen, T., Bay, T., Eriksen, J., Gether, U., and Jørgensen, T. N. (2014) The serotonin transporter undergoes constitutive internalization and is primarily sorted to late endosomes and lysosomal degradation. J. Biol. Chem. 289, 23004-23019
45. Kleta, R., Romeo, E., Ristic, Z., Ohura, T., Stuart, C., Arcos-Burgos, M., Dave, M. H., Wagner, C. A., Camargo, S. R., Inoue, S., Matsuura, N., Helip-Wooley, A., Bockenhauer, D., Warth, R., Bernardini, I., Visser, G., Eggermann, T., Lee, P., Chairoungdua, A., Jutabha, P., Babu, E., Nilwarangkoon, S., Anzai, N., Kanai, Y., Verrey, F., Gahl, W. A., and Koizumi, A. (2004) Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat. Genet. 36, 999-1002
46. Seow, H. F., Bröer, S., Bröer, A., Bailey, C. G., Potter, S. J., Cavanaugh, J. A., and Rasko, J. E. (2004) Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat. Genet. 36, 1003-1007
47. Azmanov, D. N., Kowalczuk, S., Rodgers, H., Auray-Blais, C., Giguère, R., Rasko, J. E., Bröer, S., and Cavanaugh, J. A. (2008) Further evidence for allelic heterogeneity in Hartnup disorder. Hum. Mutat. 29, 1217-1221
48. Fujiwara, M., Yamamoto, H., Miyagi, T., Seki, T., Tanaka, S., Hide, I., and Sakai, N. (2013) Effects of the chemical chaperone 4-phenylbutylate on the function of the serotonin transporter (SERT) expressed in COS-7 cells. J. Pharmacol. Sci. 122, 71-83
49. Pae, C. U., Mandelli, L., Serretti, A., Patkar, A. A., Kim, J. J., Lee, C. U., Lee, S. J., Lee, C., De Ronchi, D., and Paik, I. H. (2007) Heat-shock protein-70 genes and response to antidepressants in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1006-1011